Disc Medicine, Inc. (IRON)
NGM – Real Time Price. Currency in USD
68.53
-0.70 (-1.01%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
68.53
-0.70 (-1.01%)
At close: May 12, 2026, 4:00 PM EDT
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.
| Name | Position |
|---|---|
| Dr. Brian MacDonald ChB, MB, Ph.D. | Founder & Chair of Scientific Advisory Board |
| Dr. Donald William Nicholson Ph.D. | Executive Chairman |
| Dr. John D. Quisel Esq., J.D., Ph.D. | CEO, President & Director |
| Dr. Rahul Khara J.D., Pharm.D. | Chief Legal Officer & Secretary |
| Dr. Rahul Rajan Kaushik Ph.D. | Chief Technical Officer |
| Dr. William Jacob Savage M.D., Ph.D. | Chief Medical Officer |
| Mr. Jonathan Yu M.B.A. | Chief Opearating Officer |
| Ms. Jean M. Franchi CPA | Chief Financial Officer |
| Ms. Lisa Amaya Price | Chief Human Resources Officer |
| Ms. Pamela Stephenson M.P.H. | Chief Commercial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-05 | 8-K | iron-20260505.htm |
| 2026-05-05 | 10-Q | iron-20260331.htm |
| 2026-04-28 | DEFA14A | iron-2026_notice-defa14a.htm |
| 2026-02-27 | 8-K | iron-20260226.htm |
| 2026-02-26 | S-8 | d74535ds8.htm |
| 2026-02-26 | 10-K | iron-20251231.htm |
| 2026-02-17 | 8-K | iron-20260217.htm |
| 2026-02-13 | 8-K | iron-20260213.htm |
| 2026-01-12 | 8-K | iron-20260112.htm |
| 2025-12-08 | 8-K | iron-20251207.htm |